|
市场分析报告
|
Colorectal Cancer Market Assessment, By Treatment Type [Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, Other Treatments], By Diagnosis [In-vitro Diagnostic Testing, Imaging, Biopsy Technologies, Others], By End-user [Hospitals, Cancer Research Institutes, Ambulatory Care Centers, Others], By Region, Opportunities and Forecast, 2017-2031F ... New Drug Application (NDA) for fruquintinib, a highly selective and potent inhibitor ...
Global Colorectal Cancer Drugs Market - 2025 -2033 Colorectal Cancer Drugs Market Size and Growth The global colorectal cancer drugs market size is projected to grow from US$ 12.60 billion in 2024 to US$ 19.96 billion by 2033, registering a CAGR of 5.2% during the forecast period. The global market for ...
Hutchmed China Ltd - Company Profile and SWOT Analysis ... immunological disorders. Major products include fruquintinib, an oral inhibitor of vascular endothelial growth ...
|
|
|